SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-23-021520
Filing Date
2023-11-28
Accepted
2023-11-28 16:18:42
Documents
15
Period of Report
2023-11-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 32725
2 EXHIBIT 3.1 exhibit3-1.htm EX-3.1 14431
  Complete submission text file 0001062993-23-021520.txt   264203

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20231128.xsd EX-101.SCH 4469
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20231128_cal.xml EX-101.CAL 694
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20231128_def.xml EX-101.DEF 22200
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20231128_lab.xml EX-101.LAB 46376
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20231128_pre.xml EX-101.PRE 24829
9 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 2780
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31187 | Film No.: 231446692
SIC: 2834 Pharmaceutical Preparations